CAS No.5370-01-4,Mexiletine hydrochloride Suppliers,MSDS download

Products Categories

Pharmaceutical (85)
Organic Chemicals (15)
Others (9)
Reagent (4)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	5370-01-4
Name:	Mexiletine hydrochloride
Article Data:	5

Formula:	C₁₁H₁₇NO^.HCl
Molecular Weight:	215.723
Synonyms:	2-Propanamine,1-(2,6-dimethylphenoxy)-, hydrochloride (9CI);Ethylamine, 1-methyl-2-(2,6-xylyloxy)-,hydrochloride (7CI,8CI);Katen;Ko 1173;Ko 1173Cl;Mexiletinehydrochloride;Mexilitene;Mexitil;Ritalmex;
EINECS:	226-362-1
Density:	0.979 g/cm3
Melting Point:	200-203 °C
Boiling Point:	271.5 °C at 760 mmHg
Flash Point:	112.2 °C
Solubility:	50 mg/mL in ethanol
Appearance:	white to off-white solid
Hazard Symbols:	Xn
Risk Codes:	20/21/22-36/37/38-22
Safety:	36-26
PSA:	35.25000
LogP:	3.53170

Country:
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:90 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 5370-01-4

Specification

The IUPAC name of this chemical is 1-(2,6-dimethylphenoxy)propan-2-amine hydrochloride. With the CAS registry number 5370-01-4 and EINECS 226-362-1, it is also named as 1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride. The product's categories are Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts; Intermediates & Fine Chemicals; Pharmaceuticals; Amine Salts; Nitrogen Compounds; Organic Building Blocks. It is white to off-white solid which is stable under normal temperature and pressure. Additionally, this chemical should be sealed in the container and stored in the cool and dry place.

The other characteristics of this product can be summarized as: (1)ACD/LogP: 2.16; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.63; (4)ACD/LogD (pH 7.4): 0.96; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1.63; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 22.47; (9)#H bond acceptors: 2; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 12.47 Å²; (13)Enthalpy of Vaporization: 50.97 kJ/mol; (14)Vapour Pressure: 0.00642 mmHg at 25°C; (15)Rotatable Bond Count: 3; (16)Exact Mass: 215.107692; (17)MonoIsotopic Mass: 215.107692; (18)Topological Polar Surface Area: 35.2; (19)Heavy Atom Count: 14.

Uses of Mexiletine hydrochloride: It is a kind of Antiarrhythmic agent pharmacologically similar to Lidocaine. It may have some anticonvulsant properties.

When you are using this chemical, please be cautious about it as the following:
It is not only harmful by inhalation, in contact with skin and if swallowed, but also irritating to eyes, respiratory system and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. If you want to contact this product, you must wear suitable protective clothing.

People can use the following data to convert to the molecule structure.
1. SMILES:Cl.O(c1c(cccc1C)C)CC(N)C
2. InChI:InChI=1/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H
3. InChIKey:NFEIBWMZVIVJLQ-UHFFFAOYAV

The following are the toxicity data which has been tested.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	intravenous	19mg/kg (19mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 590, 1985.
dog	LD50	oral	356mg/kg (356mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 590, 1985.
mouse	LD50	intramuscular	128mg/kg (128mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
mouse	LD50	intraperitoneal	114mg/kg (114mg/kg)		United States Patent Document. Vol. #4731383,
mouse	LD50	intravenous	21mg/kg (21mg/kg)		Bratislavske Lekarske Listy. Vol. 85, Pg. 152, 1986.
mouse	LD50	oral	272mg/kg (272mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS	Arzneimittel-Forschung. Drug Research. Vol. 38, Pg. 1398, 1988.
mouse	LD50	subcutaneous	235mg/kg (235mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA MUSCULOSKELETAL: OTHER CHANGES	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
rabbit	LD50	oral	160mg/kg (160mg/kg)	SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
rat	LD50	intramuscular	190mg/kg (190mg/kg)	BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
rat	LD50	intravenous	27mg/kg (27mg/kg)	BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
rat	LD50	oral	330mg/kg (330mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
rat	LD50	subcutaneous	500mg/kg (500mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR MUSCULOSKELETAL: OTHER CHANGES	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 922, 1982.
women	TDLo	oral	360mg/kg (360mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: COMA LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Journal of Toxicology, Clinical Toxicology. Vol. 32, Pg. 731, 1994.